T1	PROC 29 49	dietas hipocalóricas
#1	AnnotatorNotes T1	C0420182; dietary prophylaxis low calorie; Therapeutic or Preventive Procedure
T2	CHEM 78 87	proteínas
#2	AnnotatorNotes T2	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T3	CHEM 90 103	carbohidratos
#3	AnnotatorNotes T3	C0007004; Carbohydrates; Organic Chemical
T4	Observation 110 125	pérdida de peso
#4	AnnotatorNotes T4	C1262477; Weight decreased; Finding
T5	DISO 134 159	resistencia a la insulina
#5	AnnotatorNotes T5	C0021655; Insulin Resistance; Pathologic Function
T6	CHEM 475 478	HCO
#6	AnnotatorNotes T6	C0007004; Carbohydrates; Organic Chemical
T7	Observation 198 213	pérdida de peso
#7	AnnotatorNotes T7	C1262477; Weight decreased; Finding
T8	CHEM 309 317	insulina
#8	AnnotatorNotes T8	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T9	PROC 1203 1231	Homeostasis Model Assessment
#9	AnnotatorNotes T9	C1829779; Homeostasis model assessment; Health Care Activity
T10	PROC 397 417	dietas hipocalóricas
#10	AnnotatorNotes T10	C0420182; dietary prophylaxis low calorie; Therapeutic or Preventive Procedure
T11	CHEM 448 457	proteínas
#11	AnnotatorNotes T11	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T12	CHEM 460 473	carbohidratos
#12	AnnotatorNotes T12	C0007004; Carbohydrates; Organic Chemical
T13	DISO 498 507	sobrepeso
#13	AnnotatorNotes T13	C0497406; Overweight; Finding
T14	DISO 510 516	obesos
#14	AnnotatorNotes T14	C0028754; Obesity; Disease or Syndrome
T15	DISO 530 555	resistencia a la insulina
#15	AnnotatorNotes T15	C0021655; Insulin Resistance; Pathologic Function
T16	DISO 567 592	resistencia a la insulina
#16	AnnotatorNotes T16	C0021655; Insulin Resistance; Pathologic Function
T17	PROC 613 671	Estudio prospectivo, aleatorizado, de intervención clínica
#17	AnnotatorNotes T17	C0033522; Prospective Studies; Research Activity + C0034656; Randomization; Research Activity + C3274035; Interventional Study; Research Activity
T18	DISO 717 719	IR
#18	AnnotatorNotes T18	C0021655; Insulin Resistance; Pathologic Function
T19	PROC 793 810	asignados al azar
#19	AnnotatorNotes T19	C0034656; Randomization; Research Activity
T20	CHEM 777 784	glucosa
#20	AnnotatorNotes T20	C0017725; glucose; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T21	CHEM 843 851	proteína
#21	AnnotatorNotes T21	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T22	CHEM 882 885	HCO
#22	AnnotatorNotes T22	C0007004; Carbohydrates; Organic Chemical
T23	CHEM 891 899	proteína
#23	AnnotatorNotes T23	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T24	DISO 1115 1117	IR
#24	AnnotatorNotes T24	C0021655; Insulin Resistance; Pathologic Function
T25	PROC 950 961	seguimiento
#25	AnnotatorNotes T25	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T26	Observation 998 1013	pérdida de peso
#26	AnnotatorNotes T26	C1262477; Weight decreased; Finding
T27	Observation 1080 1095	pérdida de peso
#27	AnnotatorNotes T27	C1262477; Weight decreased; Finding
T28	PROC 1233 1237	HOMA
#28	AnnotatorNotes T28	C1829779; Homeostasis model assessment; Health Care Activity
T29	PROC 1273 1280	glucosa
#29	AnnotatorNotes T29	C0337438; Glucose measurement; Laboratory Procedure
T30	PROC 1409 1429	dietas hipocalóricas
#30	AnnotatorNotes T30	C0420182; dietary prophylaxis low calorie; Therapeutic or Preventive Procedure
T31	CHEM 1461 1470	proteínas
#31	AnnotatorNotes T31	C0033684; Proteins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T32	CHEM 1473 1486	carbohidratos
#32	AnnotatorNotes T32	C0007004; Carbohydrates; Organic Chemical
T33	DISO 1531 1556	resistencia a la insulina
#33	AnnotatorNotes T33	C0021655; Insulin Resistance; Pathologic Function
T34	Observation 1613 1628	pérdida de peso
#34	AnnotatorNotes T34	C1262477; Weight decreased; Finding
T35	DISO 557 559	IR
#35	AnnotatorNotes T35	C0021655; Insulin Resistance; Pathologic Function
T36	CHEM 834 837	HCO
#36	AnnotatorNotes T36	C0007004; Carbohydrates; Organic Chemical
T37	CHEM 151 159	insulina
#37	AnnotatorNotes T37	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T38	PROC 280 285	dieta
#38	AnnotatorNotes T38	C0012167; Reducing diet; Therapeutic or Preventive Procedure
T39	CHEM 547 555	insulina
#39	AnnotatorNotes T39	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T40	CHEM 584 592	insulina
#40	AnnotatorNotes T40	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T41	PROC 740 765	prueba de tolerancia oral
#41	AnnotatorNotes T41	C0201778; Tolerance test, oral; Laboratory Procedure
T42	ANAT 761 765	oral
#42	AnnotatorNotes T42	C0226896; Oral cavity; Body Space or Junction | C0230028; Oral region; Body Location or Region | C1267547; Entire mouth region; Body Space or Junction
T43	PROC 817 822	dieta
#43	AnnotatorNotes T43	C0012167; Reducing diet; Therapeutic or Preventive Procedure
T44	CHEM 857 862	grasa
#44	AnnotatorNotes T44	C0015677; Fatty acid glycerol esters; Organic Chemical · Pharmacologic Substance
T45	PROC 864 869	dieta
#45	AnnotatorNotes T45	C0012167; Reducing diet; Therapeutic or Preventive Procedure
T46	CHEM 905 910	grasa
#46	AnnotatorNotes T46	C0015677; Fatty acid glycerol esters; Organic Chemical · Pharmacologic Substance
T47	PROC 912 917	dieta
#47	AnnotatorNotes T47	C0012167; Reducing diet; Therapeutic or Preventive Procedure
T48	PROC 1024 1030	dietas
#48	AnnotatorNotes T48	C0012167; Reducing diet; Therapeutic or Preventive Procedure
T49	PROC 1296 1304	insulina
#49	AnnotatorNotes T49	C0202098; Insulin measurement; Laboratory Procedure
T50	PROC 1339 1344	dieta
#50	AnnotatorNotes T50	C0012167; Reducing diet; Therapeutic or Preventive Procedure
T51	CHEM 1548 1556	insulina
#51	AnnotatorNotes T51	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T52	Duration 15 21	un año
T55	Date 376 389	a largo plazo
T56	LIVB 483 493	individuos
#52	AnnotatorNotes T56	C0027361; Persons; Population Group
T57	Neg_cue 563 566	sin
T58	LIVB 682 691	pacientes
#53	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T60	Dose 769 773	75 g
T61	Duration 940 946	un año
T67	Duration 1316 1331	los 120 minutos
T53	Dose 827 830	40%
T54	Dose 853 856	30%
T59	Dose 839 842	30%
T70	Dose 878 881	55%
T71	Dose 887 890	15%
T72	Dose 901 904	30%
T62	PROC 1522 1526	peso
#54	AnnotatorNotes T62	C2985231; Body Weight Measurement; Diagnostic Procedure
T63	Observation 291 317	sensibilidad a la insulina
#55	AnnotatorNotes T63	C0920563; Insulin Sensitivity; Pathologic Function
A1	Assertion T16 Negated
R1	Has_Duration_or_Interval Arg1:T1 Arg2:T52	
R2	Used_for Arg1:T2 Arg2:T1	
T64	Food 258 273	macronutrientes
#56	AnnotatorNotes T64	C2346926; Macronutrient; Food
R4	Used_for Arg1:T64 Arg2:T38	
R5	Overlap Arg1:T7 Arg2:T63	
R6	Overlap Arg1:T4 Arg2:T5	
R7	Overlap Arg1:T10 Arg2:T55	
R8	Causes Arg1:T38 Arg2:T7	
R9	Causes Arg1:T1 Arg2:T4	
R10	Used_for Arg1:T11 Arg2:T10	
R13	Experiences Arg1:T56 Arg2:T10	
R14	Experiences Arg1:T56 Arg2:T13	
R15	Experiences Arg1:T56 Arg2:T14	
R16	Experiences Arg1:T56 Arg2:T15	
R17	Experiences Arg1:T56 Arg2:T16	
R18	Negation Arg1:T57 Arg2:T16	
R19	Overlap Arg1:T14 Arg2:T15	
R20	Experiences Arg1:T58 Arg2:T18	
R21	Experiences Arg1:T58 Arg2:T41	
R22	Location_of Arg1:T42 Arg2:T41	
R23	Has_Dose_or_Strength Arg1:T20 Arg2:T60	
R24	Used_for Arg1:T20 Arg2:T41	
R25	Before Arg1:T41 Arg2:T19	
R26	Before Arg1:T19 Arg2:T43	
R27	Before Arg1:T19 Arg2:T45	
R28	Before Arg1:T19 Arg2:T47	
R29	Has_Dose_or_Strength Arg1:T36 Arg2:T53	
R30	Has_Dose_or_Strength Arg1:T21 Arg2:T59	
R31	Used_for Arg1:T36 Arg2:T43	
R34	Has_Dose_or_Strength Arg1:T44 Arg2:T54	
R32	Combined_with Arg1:T36 Arg2:T21	
R35	Combined_with Arg1:T21 Arg2:T44	
R33	Used_for Arg1:T36 Arg2:T45	
R36	Used_for Arg1:T22 Arg2:T43	
R37	Used_for Arg1:T22 Arg2:T47	
R38	Has_Dose_or_Strength Arg1:T22 Arg2:T70	
R39	Has_Dose_or_Strength Arg1:T23 Arg2:T71	
R40	Has_Dose_or_Strength Arg1:T46 Arg2:T72	
R41	Combined_with Arg1:T22 Arg2:T23	
R42	Combined_with Arg1:T23 Arg2:T46	
R43	Experiences Arg1:T58 Arg2:T43	
R44	Experiences Arg1:T58 Arg2:T45	
R45	Experiences Arg1:T58 Arg2:T47	
R46	Has_Duration_or_Interval Arg1:T25 Arg2:T61	
T65	Neg_cue 963 965	no
T66	CONC 980 991	diferencias
A2	Assertion T66 Negated
#57	AnnotatorNotes T66	C1705241; Delta (difference); Quantitative Concept
R47	Negation Arg1:T65 Arg2:T66	
R48	Causes Arg1:T48 Arg2:T26	
R49	Overlap Arg1:T25 Arg2:T48	
R50	Causes Arg1:T48 Arg2:T27	
T68	Neg_cue 1156 1158	No
T69	CONC 1174 1185	diferencias
A3	Assertion T69 Negated
#58	AnnotatorNotes T69	C1705241; Delta (difference); Quantitative Concept
R51	Negation Arg1:T68 Arg2:T69	
R52	Overlap Arg1:T49 Arg2:T67	
R57	Used_for Arg1:T31 Arg2:T30	
R58	Combined_with Arg1:T2 Arg2:T3	
R3	Combined_with Arg1:T11 Arg2:T12	
R59	Combined_with Arg1:T11 Arg2:T6	
R11	Combined_with Arg1:T31 Arg2:T32	
T73	Observation 1498 1505;1516 1526	cambios en el peso
#59	AnnotatorNotes T73	C0005911; Body Weight Changes; Finding
R12	Causes Arg1:T30 Arg2:T73	
R60	Overlap Arg1:T33 Arg2:T34	
T74	Observation 369 375	efecto
#60	AnnotatorNotes T74	C1518681; Outcome of Therapy; Finding (?)
R61	Causes Arg1:T10 Arg2:T74	
R62	Overlap Arg1:T74 Arg2:T55	
R63	Overlap Arg1:T13 Arg2:T15	
R64	Overlap Arg1:T14 Arg2:T35	
R65	Overlap Arg1:T13 Arg2:T35	
R66	Overlap Arg1:T13 Arg2:T16	
R67	Overlap Arg1:T14 Arg2:T16	
#61	AnnotatorNotes T55	C0443252; Long-term; Temporal Concept
A4	Experiencer T56 Patient
A5	Experiencer T58 Patient
R53	Has_Result_or_Value Arg1:T62 Arg2:T73	
